Lumos Pharma upgraded by Stifel with a new price target
$LUMO
Biotechnology: Pharmaceutical Preparations
Health Care
Stifel upgraded Lumos Pharma from Hold to Buy and set a new price target of $24.00 from $4.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/4/2021 | $27.00 → $28.00 | Buy | HC Wainwright & Co. |
| 7/21/2021 | $34.00 → $27.00 | Buy | HC Wainwright & Co. |